However, quantification of serum sVCAM-1 levels is currently unable to distinguish between sVCAM-1 derived from endothelial cells or tumor cells and VCAM-1 released from angiogenic lymphatic vessels [42]. This evidence concerns the gene VCAM1 and neoplasm.